Pack T D, Otten R A, Raeder R H, Boyle M D
Department of Microbiology, Medical College of Ohio, Toledo 43699.
Infect Immun. 1994 May;62(5):2104-7. doi: 10.1128/iai.62.5.2104-2107.1994.
Analysis of group A streptococcal immunoglobulin G (IgG)-binding protein reactivity with different human IgG3-myeloma proteins provided evidence for at least two functional forms of these molecules. Representative IgG3-binding molecules were isolated, biotinylated, and used as tracers in competitive binding assays. Cross-inhibition studies demonstrated the existence of two distinct patterns of IgG3-binding activity. Proteins of one form could be inhibited from binding to an IgG3-myeloma protein by streptococcal protein G while binding of the second form was not inhibited. These studies further underscore the extent of heterogeneity among immunoglobulin-binding proteins expressed by group A streptococci.
对A组链球菌免疫球蛋白G(IgG)结合蛋白与不同人类IgG3-骨髓瘤蛋白反应性的分析为这些分子的至少两种功能形式提供了证据。分离出具有代表性的IgG3结合分子,进行生物素化,并用作竞争性结合试验中的示踪剂。交叉抑制研究证明存在两种不同的IgG3结合活性模式。一种形式的蛋白与IgG3-骨髓瘤蛋白的结合可被链球菌蛋白G抑制,而第二种形式的结合则不受抑制。这些研究进一步强调了A组链球菌表达的免疫球蛋白结合蛋白之间的异质性程度。